253 related articles for article (PubMed ID: 34484233)
1. Immunoregulatory Functions of Interferons During Genital HSV-2 Infection.
Feng E; Balint E; Vahedi F; Ashkar AA
Front Immunol; 2021; 12():724618. PubMed ID: 34484233
[TBL] [Abstract][Full Text] [Related]
2. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
Elife; 2021 May; 10():. PubMed ID: 34047696
[TBL] [Abstract][Full Text] [Related]
3. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
4. Estradiol Enhances Antiviral CD4
Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
6. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
7. Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.
Sato A; Suwanto A; Okabe M; Sato S; Nochi T; Imai T; Koyanagi N; Kunisawa J; Kawaguchi Y; Kiyono H
J Virol; 2014 Dec; 88(23):13699-708. PubMed ID: 25231301
[TBL] [Abstract][Full Text] [Related]
8. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
9. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
10. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 Negatively Regulates Type I Interferon Responses and Increases Susceptibility to Herpes Genital Infection in Mice.
Gunderstofte C; Iversen MB; Peri S; Thielke A; Balachandran S; Holm CK; Olagnier D
Front Immunol; 2019; 10():2101. PubMed ID: 31555293
[TBL] [Abstract][Full Text] [Related]
12. IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.
Gardner JK; Herbst-Kralovetz MM
Cytokine; 2018 Nov; 111():63-71. PubMed ID: 30118914
[TBL] [Abstract][Full Text] [Related]
13. Evasion of the mucosal innate immune system by herpes simplex virus type 2.
Peng T; Zhu J; Klock A; Phasouk K; Huang ML; Koelle DM; Wald A; Corey L
J Virol; 2009 Dec; 83(23):12559-68. PubMed ID: 19793807
[TBL] [Abstract][Full Text] [Related]
14. Vaginal immunity in the HSV-2 mouse model.
Parr MB; Parr EL
Int Rev Immunol; 2003; 22(1):43-63. PubMed ID: 12710503
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.
Milligan GN
J Virol; 1999 Aug; 73(8):6380-6. PubMed ID: 10400730
[TBL] [Abstract][Full Text] [Related]
16. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
Gill N; Davies EJ; Ashkar AA
Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
[TBL] [Abstract][Full Text] [Related]
17. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
18. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
Çuburu N; Wang K; Goodman KN; Pang YY; Thompson CD; Lowy DR; Cohen JI; Schiller JT
J Virol; 2015 Jan; 89(1):83-96. PubMed ID: 25320297
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
20. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.
Milligan GN; Bernstein DI
Virology; 1995 Jan; 206(1):234-41. PubMed ID: 7831778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]